However, other anti-apoptotic members of the BCL-2 family proteins, including MCL-1 and BCL-XL may contribute to cell survival in BCP-ALL counteracting venetoclax sensitivity leading to poor treatment response. The gene discussed is BCL2; the disease is acute lymphoblastic leukemia.